NCT00001114 2021-11-01The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2 Completed90 enrolled